Deficiency Index

Every finding on record at Lhm Hospice and Social Services Foundation

Harrisburg, Pennsylvania · CCN 731514

3 findings across 1 survey, in the inspector's own words.

The inspector’s own words from form CMS-2567, unedited, including CMS’s own spacing. Names and some dates are redacted by CMS.

Survey of July 12, 2024

3 findings
L0530

Upon patient record review, 1 of 14 (Patient #2) did not have evidence in the patient record that a review was completed of all prescription and non-prescription medications, including herbal remedies that could affect drug therapy. This review includes, but is not limited to: • Effectiveness of drug therapy • Drug side effects • Actual or potential drug interactions • Duplicate drug therapy • Drug therapy currently associated with laboratory monitoring #2-The Medical Director recommended DC of Eliquis at IDG meeting 06/26/24. RN documented on SN Noted dated 06/27/24 that medication was to be discontinued. As of survey date 07/10/24, Eliquis continues to be listed on the medication profile as an active medication, and continues to be documented on the IDG Plan of Care Update dated 07/10/24. In addition, there was no indicator documented for as needed oxygen on the order.

L0549

Upon patient record review, 1 of 14 (Patient #2) did not have evidence the plan of care must include all services necessary for the palliation and management of the terminal illness and related conditions, including medications and treatments. #2-There was no indicator documented for as needed oxygen on the order.

L0690

Upon patient record review, 1 of 14 (Patient #2) did not have evidence that if a drug order is verbal or given via an electronic transmission, it is given to a Registered Nurse, Nurse Practitioner, pharmacist, physician or other licensed individuals as designated by state regulations. The person receiving the order records and signs it immediately and has the prescribing person sign it in accordance with state and federal regulations. #2-The Medical Director recommended DC of Eliquis at IDG meeting 06/26/24. RN documented on SN Noted dated 06/27/24 that medication was to be discontinued. As of survey date 07/10/24, Eliquis continues to be listed on the medication profile as an active medication, and continues to be documented on the IDG Plan of Care Update dated 07/10/24.

← Back to the Lhm Hospice and Social Services Foundation record

Federal survey findings only. State licensure findings for hospices are not shown.

Deficiency Index is independent and is not affiliated with, endorsed by, or approved by CMS, Medicare, or any government agency. About this data · Report a correction